BioPharma Dive - Latest News

Jazz expands in oncology with $935M deal for Chimerix

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma. 

Mar 5, 2025 - 17:55
 0
Jazz expands in oncology with $935M deal for Chimerix

Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma. 

Read More

Tags:

Previous Article

The new eIntouro successfully defies cold, ice and snow: Daimler Buses tests ele...

Next Article

Bayer braces for ‘difficult’ year before turnaround pays dividends

Related Posts

Regeneron gene therapy helps deaf children hear in small study

Regeneron gene therapy helps deaf children hear in smal...

Feb 25, 2025  0

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’...

Feb 21, 2025  0

Biogen inks royalty deal to gain funding for lupus drug R&D

Biogen inks royalty deal to gain funding for lupus drug...

Feb 12, 2025  0